Cardinal Health (CAH) stock
CAH · Cardinal Health Inc. · NYSE
- Market cap
- $63.06B
- EPS (FY)
- $7.23
- Shares out
- 231.1M
What is the latest news on CAH stock?
4 - CARDINAL HEALTH INC (0000721371) (Issuer)
All CAH newsWhen does Cardinal Health report earnings?
The latest Cardinal Health earnings release came out on Jan 9, 2024: Cardinal Health Announces Progress on Business and Portfolio Review and Fiscal 2024 Outlook Update.
CAH earnings historyWho owns the most CAH stock?
BlackRock, Inc. was the largest reported holder of CAH at the end of Q2 2026, with 26,490,633 shares worth $6.3 billion. Next came Vanguard Capital Management LLC ($3.6 billion) and Wellington Management Group LLP ($3.5 billion). In all, 1,496 institutions reported $48.9 billion of CAH in their 13F filings.
All CAH fund holdersAre insiders buying or selling CAH?
No CAH insider has reported a purchase or sale in the last 90 days. The last trade on file: Mary C. Scherer sold $546K, reported on Aug 20, 2026.
CAH insider tradesFinancial highlights
Full financials- Revenue, FY2026
- $254.25B
- Revenue growth
- +14.2%
- Net income, FY2026
- $1.71B
- Net margin
- 0.7%
- Free cash flow, FY2026
- $4.53B
- Cash
- $5.26B
For fiscal 2026 (ended Jun 30, 2026), from SEC filings. Not investment advice.
Latest news
25 items- INSIDERDirector Hall Patricia Hemingway was granted 1,204 shares, increasing direct ownership by 4% to 29,849 units (SEC Form 4)4 - CARDINAL HEALTH INC (0000721371) (Issuer)
- INSIDERDirector Johri Akhil was granted 1 shares, increasing direct ownership by 0.00% to 22,869 units (SEC Form 4)4 - CARDINAL HEALTH INC (0000721371) (Issuer)
- INSIDERDirector Killefer Nancy was granted 755 shares, increasing direct ownership by 3% to 28,379 units (SEC Form 4)4 - CARDINAL HEALTH INC (0000721371) (Issuer)
- INSIDERDirector Mundkur Christine was granted 755 shares, increasing direct ownership by 10% to 8,291 units (SEC Form 4)4 - CARDINAL HEALTH INC (0000721371) (Issuer)
- INSIDERDirector Musslewhite Robert W was granted 755 shares, increasing direct ownership by 36% to 2,871 units (SEC Form 4)4 - CARDINAL HEALTH INC (0000721371) (Issuer)
- INSIDERDirector Ramakrishna Sudhakar was granted 755 shares, increasing direct ownership by 36% to 2,871 units (SEC Form 4)4 - CARDINAL HEALTH INC (0000721371) (Issuer)
- INSIDERDirector Edison Sheri H. was granted 755 shares, increasing direct ownership by 5% to 15,603 units (SEC Form 4)4 - CARDINAL HEALTH INC (0000721371) (Issuer)
- INSIDERNew insider Zielinski Anita A claimed ownership of 5,715 shares (SEC Form 3)3 - CARDINAL HEALTH INC (0000721371) (Issuer)
- INSIDERDirector Evans David C was granted 755 shares, increasing direct ownership by 5% to 16,128 units (SEC Form 4)4 - CARDINAL HEALTH INC (0000721371) (Issuer)
- INSIDERDirector Brennan Michelle was granted 755 shares, increasing direct ownership by 9% to 8,841 units (SEC Form 4)4 - Brennan Michelle (CIK 0001827353)
- INSIDERDirector Azelby Robert was granted 755 shares, increasing direct ownership by 18% to 4,840 units (SEC Form 4)4 - Azelby Robert (CIK 0001656998)
- 13D/GAmendment: SEC Form SCHEDULE 13G/A filed by Cardinal Health Inc.SCHEDULE 13G/A - CARDINAL HEALTH INC (0000721371) (Subject)
- SECCardinal Health Inc. filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders8-K - CARDINAL HEALTH INC (0000721371) (Filer)
- PRCardinal Health Board of Directors Approves Quarterly DividendDUBLIN, Ohio, Nov. 11, 2026 /PRNewswire/ -- Cardinal Health (NYSE:CAH) announced today that its Board of Directors approved its quarterly dividend of $0.5158 per share, out of the Company's capital surplus. The dividend will be payable on January 15, 2027 to shareholders of record at the close of business on January 4, 2027. About Cardinal HealthCardinal Health is a distributor of pharmaceuticals and specialty products; a global manufacturer and distributor of medical and laboratory products; a supplier of home-health and direct-to-patient products and services; an operator of nuclear pharmacies and manufacturing facilities; an
- SECSEC Form 10-Q filed by Cardinal Health Inc.10-Q - CARDINAL HEALTH INC (0000721371) (Filer)
- SECCardinal Health Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Regulation FD Disclosure, Financial Statements and Exhibits8-K - CARDINAL HEALTH INC (0000721371) (Filer)
- PRCardinal Health Reports First Quarter Fiscal Year 2027 Results and Raises OutlookFirst quarter revenue increased 5% to $67.5 billionGAAP1 operating earnings increased 13% to $753 million; GAAP diluted EPS increased 27% to $2.38Non-GAAP operating earnings increased 17% to $1.0 billion; non-GAAP diluted EPS increased 28% to $3.26Cardinal Health raises fiscal year 2027 non-GAAP EPS guidance2 to $12.80 to $13.00, 17% to 19% growth3 from its FY26 ex-tariff refund baseline and 14% to 15% growth from reported FY26 resultsCardinal Health completes $500 million share repurchase program in first quarterDUBLIN, Ohio, Nov. 5, 2026 /PRNewswire/ -- Cardinal Health (NYSE:CAH) today reported first quarter fiscal year 2027 revenues of $67.5 billion, an increase of 5% from the first quart
- SECCardinal Health Inc. filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits8-K - CARDINAL HEALTH INC (0000721371) (Filer)
- PRCardinal Health Enters into Binding Letter of Intent to Extend Pharmaceutical Distribution Agreements with CVS HealthDUBLIN, Ohio, Oct. 1, 2026 /PRNewswire/ -- Cardinal Health (NYSE:CAH) announced today that it has entered into a binding Letter of Intent to extend its existing distribution agreement with CVS Health through June 30, 2032, reflecting the continuation of Cardinal Health's current scope of distribution services."We value our long-standing partnership with CVS Health and look forward to continuing to bring our best-in-class capabilities together to serve their customers," stated Jason Hollar, CEO of Cardinal Health.In connection with the renewal, Cardinal Health has reaffirmed its fiscal year 2027 non-GAAP EPS guidance of 13% to 15% growth1 ($12.40 to $12.60) and its long-term non-GAAP EPS grow
- PRCardinal Health to Announce First-Quarter Results for Fiscal Year 2027 on November 5DUBLIN, Ohio, Oct. 1, 2026 /PRNewswire/ -- Cardinal Health (NYSE:CAH) plans to release first-quarter financial results for its fiscal year 2027 on November 5, prior to the opening of trading on the New York Stock Exchange. The company will webcast a discussion of these results beginning at 8:30 a.m. Eastern.To access the webcast and corresponding slide presentation, visit Cardinal Health's Investor Relations page. No access code is required. Presentation slides and a webcast replay will be available on the Investor Relations page for 12 months.About Cardinal HealthCardinal Health is a distributor of pharmaceuticals and specialty products; a supplier of home-health and direct-to-patient produ
- SECSEC Form DEF 14A filed by Cardinal Health Inc.DEF 14A - CARDINAL HEALTH INC (0000721371) (Filer)
- SECSEC Form DEFA14A filed by Cardinal Health Inc.DEFA14A - CARDINAL HEALTH INC (0000721371) (Filer)
- INSIDERChief Accounting Officer Scherer Mary C. sold $546,473 worth of shares (2,302 units at $237.39), decreasing direct ownership by 45% to 2,811 units (SEC Form 4)4 - CARDINAL HEALTH INC (0000721371) (Issuer)
- INSIDERChief Executive Officer Hollar Jason M. sold $29,375,516 worth of shares (124,529 units at $235.89), decreasing direct ownership by 40% to 190,603 units (SEC Form 4)4 - CARDINAL HEALTH INC (0000721371) (Issuer)
- INSIDERCEO, GMPD Segment Mason Stephen M sold $8,274,117 worth of shares (35,000 units at $236.40), decreasing direct ownership by 66% to 18,061 units (SEC Form 4)4 - CARDINAL HEALTH INC (0000721371) (Issuer)
CAH rankings
- Insider11(50%)
- SEC Filings6(27%)
- Other2(9%)
- Dividends2(9%)
- 13D/G1(5%)
Our reporting on CAH
- Cardinal Health raises FY27 EPS guide $0.40, but the $0.32 Q1 beat is 80% of it and the implied Q2 to Q4 run rate sits below Q1Analysis · Nov 6, 2026 · 6 min read

- BD's Q4 growth of 5.6% beats the 3.9% full-year pace, but receivables rose 15.6% and current debt nearly doubledAnalysis · Nov 5, 2026 · 6 min read

Cardinal Health Inc. (CAH) is an Other Pharmaceuticals company listed on NYSE. In the last 30 days Quantisnow tracked 17 wire items for CAH, including 11 insider trades, 3 SEC filings and 2 dividend updates. The most recent was published Nov 16, 2026.
CAH FAQ
9 questionsWhat does Cardinal Health Inc. do?
Cardinal Health, Inc. operates as an integrated healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home. The company operates in two segments, Pharmaceutical and Medical. The Pharmaceutical segment distributes branded and generic pharmaceutical, specialty pharmaceutical, and over-the-counter healthcare and consumer products. The segment also provides services to...What is CAH revenue?
Cardinal Health Inc. (CAH) reported $254.25B of revenue for fiscal 2026 (ended Jun 30, 2026). That is up 14.2% from the year before.Is CAH profitable?
Yes. Cardinal Health Inc. earned $1.71B in net income for fiscal 2026 (ended Jun 30, 2026), a net margin of 0.7%.How much cash and debt does CAH have?
Cardinal Health Inc. reported $5.26B in cash and cash equivalents and $6.93B of debt on its most recent balance sheet in SEC filings.Where does CAH stock trade?
Cardinal Health Inc. (CAH) is listed on NYSE.What sector and industry is CAH in?
Cardinal Health Inc. operates in the Health Care sector, Other Pharmaceuticals industry.What are analysts saying about CAH?
Across the last 8 analyst actions on Cardinal Health Inc., there were 5 upgrades and 0 downgrades. The most recent action was from RBC Capital Mkts: Outperform with a $276.00 price target on 2026-08-19. Recent price targets range from $140.00 to $276.00.What companies are similar to CAH?
Notable peers in the same industry include MDT (Medtronic plc.), HSIC (Henry Schein Inc.), BDX (Becton Dickinson and Company), MCK (McKesson Corporation), COR (Cencora Inc.). Compare CAH side-by-side with any of them on Quantisnow.How can I track CAH on Quantisnow?
Quantisnow aggregates Cardinal Health Inc.'s SEC filings, analyst ratings, insider transactions, FDA approvals, and press releases the moment they hit the wire (Wall Street's wire, on your screen.). Follow CAH to receive live email and push alerts on every new disclosure.
Is something on this page wrong, or out of date? Request a change